These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38836911)

  • 1. Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer.
    Okuda Y; Shimura T; Abe Y; Iwasaki H; Nishigaki R; Fukusada S; Sugimura N; Kitagawa M; Yamada T; Taguchi A; Kataoka H
    J Gastroenterol; 2024 Jul; 59(7):572-585. PubMed ID: 38836911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel urinary protein biomarker panel for early diagnosis of gastric cancer.
    Shimura T; Dayde D; Wang H; Okuda Y; Iwasaki H; Ebi M; Kitagawa M; Yamada T; Yamada T; Hanash SM; Taguchi A; Kataoka H
    Br J Cancer; 2020 Nov; 123(11):1656-1664. PubMed ID: 32934343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
    J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a fecal immune-related protein-based biomarker panel for colorectal cancer diagnosis: a multicenter study.
    Zhang H; Zuo L; Li J; Geng Z; Ge S; Song X; Wang Y; Zhang X; Wang L; Zhao T; Deng M; Chai D; Wang Q; Yang Z; Liu Q; Qiu Q; He X; Yang Y; Ge Y; Wu R; Zheng L; Li J; Chen R; Sun J; Hu J
    Front Immunol; 2023; 14():1126217. PubMed ID: 37313408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of kininogen-1 as a serum biomarker for the early detection of advanced colorectal adenoma and colorectal cancer.
    Wang J; Wang X; Lin S; Chen C; Wang C; Ma Q; Jiang B
    PLoS One; 2013; 8(7):e70519. PubMed ID: 23894665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
    Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
    Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 10. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
    Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
    EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
    Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
    J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis.
    Niedermaier T; Balavarca Y; Brenner H
    Am J Gastroenterol; 2020 Jan; 115(1):56-69. PubMed ID: 31850933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.
    Sun Y; Zhang X; Hang D; Lau HC; Du J; Liu C; Xie M; Pan Y; Wang L; Liang C; Zhou X; Chen D; Rong J; Zhao Z; Cheung AH; Wu Y; Gou H; Wong CC; Du L; Deng J; Hu Z; Shen H; Miao Y; Yu J
    Cancer Cell; 2024 Aug; 42(8):1386-1400.e8. PubMed ID: 39137727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
    Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of urinary biomarker panel and PancRISK score for earlier detection of pancreatic cancer: A case-control study.
    Debernardi S; O'Brien H; Algahmdi AS; Malats N; Stewart GD; Plješa-Ercegovac M; Costello E; Greenhalf W; Saad A; Roberts R; Ney A; Pereira SP; Kocher HM; Duffy S; Blyuss O; Crnogorac-Jurcevic T
    PLoS Med; 2020 Dec; 17(12):e1003489. PubMed ID: 33301466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
    Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
    Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.